Enlightenment Research, LLC Amgen Inc Transaction History

Enlightenment Research, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$230.71 - $256.74 $299,923 - $333,762	1,300 New	1,300 $316,000
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $482,394 - $533,654	-2,200 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $437,536 - $500,720	2,200 New	2,200 $495,000
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $303,654 - $336,882	-1,300 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $288,483 - $336,180	1,300 New	1,300 $323,000
Q1 2020 May 08, 2020	SELL	$182.24 - $241.7 $419,152 - $555,910	-2,300 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $548,709 - $705,280	-2,900 Reduced 55.77%	2,300 $554,000
Q3 2019 Oct 16, 2019	SELL	$174.11 - $208.62 $191,521 - $229,482	-1,100 Reduced 17.46%	5,200 $1.01 Million
Q2 2019 Aug 05, 2019	BUY	$166.7 - $195.41 $1.05 Million - $1.23 Million	6,300 New	6,300 $1.14 Million

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Enlightenment Research, LLC, based on Form 13F filings with the SEC.

Stay updated on Enlightenment Research, LLC with notifications on news.